The treatment of tardive dyskinesia.
The causes and the pathogenesis of tardive dyskinesia are not well understood. There is no therapy currently available that has been shown to alter the overall course. However, it is possible to influence the development or the progression of this disorder. A decision tree of feasible therapeutic choices is presented here, to prevent or treat tardive dyskinesia in patients who need long term neuroleptic therapy.
Raja
M
M
Psychiatry Service, S. Spirito Hospital Mental Health Department USL RME, Rome, Italy.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008134:Long-Term Care; D009460:Neurologic Examination / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000209:etiology
D014150:Antipsychotic Agents; D003024:Clozapine